Standout Papers

RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes 2024 202651
  1. RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes (2024)
    Ilse Dieussaert, Joon Hyung Kim et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 60 standout
Sub-graph 1 of 23

Citing Papers

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Wearable Digital Health Technologies for Monitoring in Cardiovascular Medicine
2024 Standout
2 intermediate papers

Works of Wenji Pu being referenced

MEDI0382, a GLP‐1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single‐dose, healthy‐subject, randomized, Phase 1 study
2018
Combined Heart Failure Device Diagnostics Identify Patients at Higher Risk of Subsequent Heart Failure Hospitalizations
2010

Author Peers

Author Last Decade Papers Cites
Wenji Pu 384 68 67 9 566
Jean-Pierre Boissel 507 31 102 11 613
Raymond J. Matta 261 30 121 13 550
Joanne Simpson 399 101 87 21 643
Lorraine Kearney 313 67 62 13 526
Ayman S. Al-Khadra 563 20 51 14 643
Takeo Onose 430 32 54 15 515
Jane Neill 474 40 181 10 639
Susan E. Ammon 477 67 46 12 586
Rosanna Greco 503 40 66 10 631
Steve Garratt 285 125 32 6 591

All Works

Loading papers...

Rankless by CCL
2026